课题基金 / 基金详情

Testing if the addition of oestrogen lowering treatment to preoperative chemotherapy better reduces the size of large oestrogen receptor positive breast cancer

Testing if the addition of oestrogen lowering treatment to preoperative chemotherapy better reduces the size of large oestrogen receptor positive breast cancer
测试在术前化疗中添加降低雌激素的治疗​​是否可以更好地减小大雌激素受体阳性乳腺癌的大小
批准号:
nhmrc : GNT1066479
负责人:
A/Pr Andrew Redfern
金额:
$218.23万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 --

项目摘要

项目成果

A/Pr Andrew Redfern的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Women diagnosed with large oestrogen receptor positive breast cancer are often treated with chemotherapy before surgery to reduce the size of the cancer, while treatment to lower oestrogen levels is given after surgery. This trial is studying if combining chemotherapy with oestrogen lowering treatment before surgery will better shrink the cancer which can improve the surgery options.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
  • 批准号:
    nhmrc : GNT1147528
  • 项目类别:
    Project Grants
  • 资助金额:
    $133.37万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
  • 批准号:
    nhmrc : 1147528
  • 项目类别:
    Project Grants
  • 资助金额:
    $90.17万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
  • 批准号:
    nhmrc : GNT1121199
  • 项目类别:
    Project Grants
  • 资助金额:
    $74.87万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
  • 批准号:
    nhmrc : 1121199
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.15万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
海外基金